
Octiocor is a cardiovascular technology company focused on preventing heart attacks in high-risk patients through its revolutionary AI-based intracoronary imaging (ICI) analysis software, AutoOCT™. This platform empowers clinicians with advanced tools for in-depth analysis of Optical Coherence Tomography (OCT) images, enabling the detection of high-risk vulnerable plaques. AutoOCT™ automates the analysis of these images, correcting artifacts, identifying tissue interfaces, and measuring critical lumen and plaque parameters, thereby reducing inter-observer variability and delivering results in minutes. The company targets clinical trials and research analysis, with future development including IVUS and hybrid imaging. Octiocor's team includes founders with expertise in cardiology, imaging, and AI from the University of Cambridge.

Octiocor is a cardiovascular technology company focused on preventing heart attacks in high-risk patients through its revolutionary AI-based intracoronary imaging (ICI) analysis software, AutoOCT™. This platform empowers clinicians with advanced tools for in-depth analysis of Optical Coherence Tomography (OCT) images, enabling the detection of high-risk vulnerable plaques. AutoOCT™ automates the analysis of these images, correcting artifacts, identifying tissue interfaces, and measuring critical lumen and plaque parameters, thereby reducing inter-observer variability and delivering results in minutes. The company targets clinical trials and research analysis, with future development including IVUS and hybrid imaging. Octiocor's team includes founders with expertise in cardiology, imaging, and AI from the University of Cambridge.